Minimed Group (NASDAQ:MMED) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $0.11 by 718.18 percent. This is unchanged from the same period last year. The company reported quarterly sales of $837.000 million which beat the analyst consensus estimate of $789.096 million by 6.07 percent. This is a 15.61 percent increase over sales of $724.000 million the same period last year.